 Daxor Corporation NYSE MKT: DXR, an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume measurement, today announced that the U.S. Air Force USAF has awarded Daxor a contract to define specifications to adapt blood volume analysis technology to meet the needs of USAF. The selection was made under the USAFs Small Business Innovative Research SBIR program. 